Read + Share
Nyein PP, Donoghoe MW, Eriobu N, Uche B, et al. Cardiometabolic impact of dolutegravir as second-line therapy: secondary analysis
of a randomized controlled trial. AIDS 2026 Mar 3. doi: 10.1097/QAD.0000000000004476.
PMID: 41779383
|
 |
|
Nyein PP, Donoghoe MW, Eriobu N, Uche B, et al. Cardiometabolic impact of dolutegravir as second-line therapy: secondary analysis
of a randomized controlled trial. AIDS 2026 Mar 3. doi: 10.1097/QAD.0000000000004476.
PMID: 41779383
|
|
|
|